10-Q: PreAxia Health Care Payment Systems Inc. Reports Q2 2025 Results, Cites Going Concern Uncertainty

PreAxia Health Care Payment Systems Inc. reported its financial results for the quarter ended November 30, 2024, highlighting a net loss and ongoing concerns about the company's ability to continue as a going concern.

Summary

• PreAxia Health Care Payment Systems Inc. has released its unaudited condensed consolidated financial statements for the quarter ended November 30, 2024.
• The company reported a net loss of $18,293 for the six-month period ended November 30, 2024, compared to a net loss of $86,028 for the same period in 2023.
• The company's cash balance increased to $165 as of November 30, 2024, from $14 as of May 31, 2024.
• PreAxia has a working capital deficit of $2,414,472 as of November 30, 2024.
• The company's operations are primarily conducted through its subsidiary, PreAxia Health Care Payment Ltd.
• There is substantial doubt about the company's ability to continue as a going concern due to its losses and lack of revenue.
• The company plans to raise an estimated $1,000,000 over the next twelve months to fund operations and complete its business plan.
• The company had no revenue for the three and six months ended November 30, 2024 and 2023.
• The company's total expenses for the six months ended November 30, 2024 were $18,293 compared to $86,028 for the same period in 2023.

Sentiment

Score: 2

Explanation: The document indicates significant financial challenges, including a lack of revenue, substantial losses, and a going concern warning, which suggests a very negative outlook from an investment perspective.

Positives

• The company's net loss decreased significantly from $86,028 to $18,293 for the six-month period year-over-year.
• The company's cash balance increased from $14 to $165 during the period.
• Total expenses decreased substantially from $86,028 to $18,293 for the six-month period year-over-year.

Negatives

• The company has a significant working capital deficit of $2,414,472.
• The company has no revenue for the reported periods.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company's disclosure controls and procedures were deemed not effective as of November 30, 2024.

Risks

• The company's ability to continue as a going concern is uncertain due to its losses and lack of revenue.
• The company needs to raise $1,000,000 over the next twelve months to fund operations, and there is no guarantee that this capital will be secured.
• The company's working capital deficit is substantial.
• The company's disclosure controls and procedures were deemed not effective as of November 30, 2024.
• The company is in the startup stage and has no cash flow from operating activities.

Future Outlook

The company plans to raise an estimated $1,000,000 over the next twelve months to fund operations and complete its business plan, primarily through the private placement of equity securities or loans.

Management Comments

• Management believes that there are no current matters that would have a material effect on the company's financial position or results of operations.
• Management has concluded that the disclosure controls and procedures were not effective as of November 30, 2024.
• The company's officers or principal shareholders are committed to making advances or loans to pay for certain legal, accounting, and administrative costs.

Industry Context

The company operates in the emerging health payment market, specifically targeting the growth of health spending accounts (HSAs), which is a growing trend in the healthcare and financial services industries.

Comparison to Industry Standards

• The company's lack of revenue and significant net losses are not in line with industry standards for established companies in the healthcare payment processing sector.
• The company's reliance on related party loans and advances is not typical of larger, more established companies in the industry.
• The company's stated need to raise $1,000,000 in the next 12 months is indicative of a startup or early-stage company, which is not comparable to established players in the market such as Optum Financial or HealthEquity, which have significant revenue and assets.
• The company's lack of operational cash flow and reliance on external funding is a significant deviation from industry leaders who typically generate positive cash flow from operations.

Related Party Transactions

• Accounts payable and accrued liabilities of $300,000 are due to Tom Zapatinas, the Chief Executive Officer and a Director of the Company.
• Advances payable of $96,297 are due to Tom Zapatinas.
• Loans payable to shareholders are $191,330.
• A promissory note of $466,817 is due to Tom Zapatinas.
• A convertible note payable of $1,058,760 is due to Tom Zapatinas.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and the potential for dilution from future equity issuances.
• Employees may be impacted by the company's financial difficulties and potential for scaling down or ceasing operations.
• Customers and suppliers may be affected by the company's uncertain future and ability to fulfill its obligations.
• Creditors face the risk of non-payment due to the company's financial challenges.

Next Steps

• The company plans to raise additional capital to execute its business plans.
• The company intends to penetrate the health care processing markets in Canada, the United States and worldwide.
• The company plans to build up a network of strategic alliances with health insurance companies and governments.
• The company intends to fill senior management, sales, administrative and engineering positions.

Key Dates

Keywords

healthcare payment systems, health spending accounts, financial results, going concern, capital raise, working capital deficit, net loss, operating expenses, related party transactions